# Chimeron Bio Corporation

Canonical: https://abierto.us/vendors/chimeron-bio-corporation-ge9qepp5xca3

- UEI: GE9QEPP5XCA3
- CAGE: 7KN25
- Parent: Chimeron Bio Corp.
- Location: Philadelphia, PA
- Awards in window: 1 (3 transactions), $300,000 obligated, February 21, 2024 to February 12, 2025

## Awarding agencies

- National Institutes of Health: 1 awards, $300,000

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): $300,000

## Competition

- Full and Open Competition After Exclusion of Sources: 1 awards

## Largest awards

- 75N91024C00011 (definitive contract): $300,000, NIH NCI. Phase I Therapeutic Award: Chimeric Nanoparticle Delivery of an Sarna-Based Cancer Vaccine for Familial Adenomatous Polyposis. https://www.usaspending.gov/award/CONT_AWD_75N91024C00011_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/chimeron-bio-corporation-ge9qepp5xca3.